October 31, 2014 9:35 AM ET

Biotechnology

Company Overview of Endacea, Inc.

Company Overview

Endacea, Inc., a biopharmaceutical company, develops a series of A1 adenosine receptor antagonists. It offers L-97-1, a compound for the prevention and early treatment of asthma with a dual mechanism of action, including the prevention of bronchoconstriction and inflammation. The company also develops an endotoxin assay as a biomarker for patients at risk of sepsis. In addition, it provides P2X purinoceptor antagonists to treat ischemia-reperfusion organ injury and sepsis, as well as disorders resulting in fibrosis and sclerosis, which comprise autoimmune diseases and inflammation; and immune system disorders, including HIV/AIDS, and other indications. Endacea was formerly known as Link Tech...

Two Davis Drive

Research Triangle Park, NC 27709

United States

Founded in 1995

Phone:

919-406-1888

Fax:

919-406-1838

Key Executives for Endacea, Inc.

Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Allos Therapeutics, Inc. United States
KromaTiD, Inc. United States
Profectus Biosciences, Inc. United States
CSL Plasma, Inc. United States
Marcadia Biotech, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Endacea, Inc., please visit www.endacea.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.